Latest biotechnology Stories
SEATTLE, WA, May 2, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, May 9, 2013 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its first quarter 2013 financial results and provide a review of its pipeline of products in development. To participate in the call by telephone, please dial (877) 280-7291 (United States) or (707) 287-9361 (International). In addition, the call will be webcast live and...
Competition from generics, pricing pressures, and decreasing healthcare spending ripples the market MOUNTAIN VIEW, Calif., May 2, 2013 /PRNewswire/ -- In the face of reduced profit margins for the pharmaceutical and biotechnology sectors, an effective financial management strategy is central to maintain sustainable growth. New analysis from Frost & Sullivan's (http://www.financialservices.frost.com) Financial Assessment of the Global Pharmaceutical and Biotechnology Industry...
RICHMOND, Calif., May 2, 2013 /PRNewswire/ -- Lumiphore, Inc., a biotechnology leader in new proprietary bi-functional metal-chelation technology for use in targeted radiopharmaceuticals has announced that Algeta ASA (OSE:ALGETA), a company focused on the development of novel targeted cancer therapeutics, has exercised its option to take an exclusive worldwide licence to Lumiphore's patented Lumi4(®) bi-functional chelator technology and has extended the collaboration to include...
GERMANTOWN, Md., May 1, 2013 /PRNewswire/ -- Intrexon Corporation, a next generation synthetic biology company, today announced that it has closed a Series F preferred investment round of $150 million, bringing the company's total capital raised to $509 million. New investors accounted for the majority of the round, with current investors, including affiliates of Randal J. Kirk, Intrexon's Chairman and CEO, and Third Security, LLC, taking the balance of the round. The funding will be...
AUSTIN, Texas, May 1, 2013 /PRNewswire/ -- XBiotech announced today that John Simard, Chairman, President & Chief Executive Officer, will present at the UBS Global Healthcare Conference in New York, NY on Monday, May 20(th) at 1:30pm ET. The conference will take place at the Sheraton New York Hotel May 20-22, 2013. John Simard remarked "XBiotech is delighted to be invited by UBS to present at this prestigious venue. UBS is one of the greatest financial institutions in the world...
App Tracks Distances to Raise Funds for Charity; Lifeway Adds 25 Cents Per Mile for Runners & Walkers MORTON GROVE, Ill., May 1, 2013 /PRNewswire/ -- Lifeway Foods, Inc., (NASDAQ: LWAY), a leading supplier of kefir cultured dairy products, today announced its sponsorship of the Charity Miles running, walking and biking app in support of The One Fund Boston fundraising initiative benefiting victims of the Boston Marathon bombing tragedy. During the free two-week campaign, Lifeway will...
World-renowned cellular and aging experts bring everycell supplement to market MONTCLAIR, N.J., May 1, 2013 /PRNewswire/ -- CellHealth(TM) Institute, a biotechnology company focused on cellular health, research and holistic lifestyle education, today launched its cell health formula, everycell(TM). (Photo: http://photos.prnewswire.com/prnh/20130501/LA05313) (Logo: http://photos.prnewswire.com/prnh/20130327/LA84207LOGO) Developed by a team of cell health and aging experts, and...
WARRINGTON, Pa., May 1, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the release of two peer-reviewed publications related to AFECTAIR(®), the Company's proprietary aerosol-conducting airway connector designed with the goal of simplifying and improving aerosolized medication delivery to infants requiring mechanical ventilation in the...
Many diseases – obesity, Type 2 diabetes, muscular dystrophy – are associated with fat accumulation in muscle. In essence, fat replacement causes the muscles to weaken and degenerate. Scientists at Wake Forest Baptist Medical Center have discovered the biological mechanism involved in this process, which could point the way to potential therapies. The findings are published in the April 27 online edition of Stem Cells and Development. The Wake Forest Baptist researchers proved that...
Mammalian females ovulate periodically over their reproductive lifetimes, placing significant demands on their ovaries for egg production. Whether mammals generate new eggs in adulthood using stem cells has been a source of scientific controversy. If true, these "germ-line stem cells" might allow novel treatments for infertility and other diseases. However, new research from Carnegie's Lei Lei and Allan Spradling demonstrates that adult mice do not use stem cells to produce new eggs. Their...
Latest biotechnology Reference Libraries
Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...
Cell is a peer-reviewed scientific journal founded by Benjamin Lewin in January 1974 with the sponsorship of MIT Press. Lewin bought the rights to the journal in 1986 and published it under his own publishing arm Cell Press. Cell Press was sold to Elsevier in 1999, which currently publishes Cell twice monthly. Cell Press publishes several biomedical journals, including Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry &...
Agrobacterium tumefaciens is the causal agent of crown gall disease (the formation of tumours) in over 140 species of dicot. It is rod shaped. Symptoms are caused by the insertion of a small segment of DNA into the plant cell. It is an alphaproteobacterium of the family Rhizobiaceae which includes the nitrogen fixing legume symbionts. They are pathogenic and provide no benefit to the plant. It also affects a wide variety of plants. In an economical sense it affects walnuts, grape vines,...
